Figure 4.PCA and independent prognostic analysis of the signature. PCA based on all genes (A), all lncRNAs (B), ICD-related lncRNAs (C), and risk signature (D); Univariate (E) and multivariate (F) independent prognostic analysis.
Figure 4 — Construction and validation of a model based on immunogenic cell death-associated lncRNAs to predict prognosis and direct therapy for kidney renal clear cell carcinoma | Aging
